A 37-year-old man developed encephalopathy with prominent eosinophilia. Magnetic resonance imaging (MRI) revealed multiple T2-weighted high signal intensity lesions with dimeglumine gadopentetate (Gd-DTPA) enhancement on Tl-weighted images, which were distributed in the cerebral cortex, thalamus, deep white matter and cerebellum. He was diagnosed as having systemic mastocytosis on the basis ofproliferating mast cells in the bone marrowand peripheral eosinophilia. Following steroid administration, there was a rapid improvementof his symptomsand laboratory data. To our knowledge, this was the first reported case of systemic mastocytosis provoking encephalopathy with serial MRIfindings. (Internal Medicine 33: 23-26, 1994) 
Introduction
Systemic mastocytosis is a rare disease entity characteristic of primary mast cell proliferation, and involves the systemic organs such as skin, liver, spleen, lung, heart, lymph nodes and bone marrow (1) (2) (3) (4) . This disease is known to exhibit various kinds of clinical manifestations, but no central nervous system involvement had been confirmed radiologically. Wepresent a rare case of encephalopathy associated with systemic mastocytosis showing peculiar magnetic resonance imaging (MRI) findings.
Case Report
A 37-year-old male patient, with an approximately twentyyear history of hypereosinophilic syndrome (HES), showed symptoms of gradual consciousness impairment and fever. The patient had often suffered from urticaria since his childhood, irrespective of diet. Three days prior to admission, he was febrile at 39°C but did not show flu-like symptoms or headache. The patient was admitted to Hokuyukai Neurological Hospital with suspected acute exacerbation of hypereosinophilic syndrome, as the peripheral white blood cell (WBC) count was 23,300/mm3 with 7% segmented cells, 4% lymphocytes and 87% eosinophils. Neurologically, he was somnolent and could be aroused by painful stimuli but soon drifted back to sleep. In addition, slight nuchal rigidity was noted as well as slight tremors in the jaws. Cerebrospinal fluid (CSF) examination revealed pleocytosis of 19 cells/mm3, protein 0.51 g/L and glucose 0.53 g/L. Electroencephalogram (EEG) was markedly abnormal, showing poor background of alpha-rhythm with prominent diffuse slowing, but no epileptiform discharges were observed. T2-weighted MRIexhibited multiple high signal intensity lesions in the basal ganglia, cerebral deep white matter and cerebellum (Fig. la) . Methylprednisolone 1 g was administered for three days and then the patient was transferred to our neurological service for further evaluation and treatment. Onadmission, the patient was lethargic and disoriented as to time and place. The cranial nerves were intact, and the muscle tone was increased in all four extremities. The deep tendon reflexes were symmetrically hyperactive and the plantar responses were extensor bilaterally. Coordination was intact. No sensory abnormalities were noted. WBCin peripheral blood was 10,100/mm3 with 13% eosinophils. IgE and vitamin B12 rose to 28,620 IU/ML (normal 250 IU/ML>), and 1,790 pg/ml Results of karyotype analysis were completely normal. Abdominal CT scans showed slight hepatomegaly and splenomegaly, but mediastinal or visceral lymphadenopathy was not found. The scintigrams of the bone with 99mTcand of the whole body with 67Ga exhibited focal uptake in the clivus, but no other skeletal activity. T2-weighted MRIrevealed multiple high signal intensity areas in the cerebral cortex, cerebral deep white matter, thalamus and cerebellum (Fig. lb) . Following the administration of dimeglumine gadopentetate (Gd-DTPA), some of these lesions were highly enhanced (Fig.   lc) . Moreover, there was an enhanced lesion in the clivus compatible with scintigraphical findings (data not shown). Bone marrowexamination showedan increased numberof mast cells with mature eosinophils presumably reactive to mast cell proliferation (Fig. 2) .
Several days after steroid treatment, the patient became alert and responded normally to questions and commands. EEG showed nearly normal findings in accordance with his improvement. Peripheral eosinophilia was also diminished. Vitamin B12 and plasma histamine levels decreased to 693 pg/ml (normal 210-1 ,200 pg/ml) and 0.46 | ig/dl (normal 0.8 | ig/dl>), respectively. T2-weighted MRI showed that high signal intensity areas in the cerebral cortex, cerebral deep white matter, thalamus and cerebellum still remained (Fig. Id) , whereas enhancement of the Tl-weighted MRIwith Gd-DTPAcould Cranial MRIof Systemic Mastocytosis In spite of the administration of 1 g methylprednisolone for three days, axial T2-weighted MRI (1.5 Tesla, 3,000/90:TR/TE) exhibited high signal intensity in the cerebral white matter, thalamus and cerebellum (b). These lesions were highly enhanced with dimeglumine gadopentetate (Gd-DTPA) (1.5 Tesla, Tl -weighted image, 600/15:TR/TE) (c). Five weeks after admission, axial T2-weighted MRI (1.5 Tesla, 3,000/90:TR/TE) was still unchanged (d), but enhancements with Gd-DTPA (1.5 Tesla, Tl -weighted image, 600/15:TR/TE) were diminished in accordance with clinical improvements (e). Some Tl-weighted low signal intensity lesions were also identified (e). not be identified (Fig. le) . During the course of his illness, auditory brainstem responses (ABR), somatosensory evoked potential (SEP) and nerve conduction velocities were all intact. Subsequently, the steroid was tapered and he was discharged with minimal steroid intake to suppress the abnormalities in the blood examinations. Since being discharged, the patient has exhibited no evidence of recurrence.
Discussion
The most characteristic rinding of our case was the encephalopathy with prominent eosinophilia. In general, peripheral eosinophilia is associated with various kinds of disorders such as parasitic or bacterial infection, allergic disease, neoplasms, skin disease, hematological disease, and collagenvasculitis disease. Additionally, except for those well-known causes, Hardy and Anderson introduced the term "hypereosinophilic syndrome (HES)" in 1968 (5) and subsequently Chusid and colleagues proposed its diagnostic criteria (6) .
Despite full examinations for an enlarged lymph node 20 years prior, the primary cause could not be found and the present patient was diagnosed as HES. Howeverat that time, we were able to establish a diagnosis of systemic mastocytosis because bone marrowexaminations revealed an increased number of mast cells and presumed reactive mature eosinophils.
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If, on the other hand, the patient had exhibited a different clinical phase of systemic mastocytosis and only a few mast cells had remained in the bone marrow, they may have been overlooked. The possible effect of the corticosteroid prescribed prior to the bone marrowexamination should also be considered. Although a large numberof eosinophils could also have induced most of his clinical symptoms, we considered that his primary pathogenetic event was the abnormally proliferating mast cells, partly because marked eosinophilia had rapidly decreased following the steroid treatment.
Our speculation was supported by previous reports which have shownthat mast cells can secrete chemical mediators such as eosinophil-chemotactic-factor (ECF) and eosinophils can proliferate in response to those mediators (7). Since both the proliferating eosinophils and mast cells were mature and not showing a malignant appearance, we excluded the possibilities of eosinophilic leukemia and mast cell leukemia. The results of the karyotype analysis also supported our evaluation. Apart from encephalopathy, clinical features including frequent urticaria, hepatosplenomegaly , peripheral eosinophilia, elevated plasma histamine and IgE were all consistent with systemic mastocytosis. Since the increased level of histamine in the first examination was relatively low, the administration of corticosteroid had probably affected the value. Compared with the second examination, the increase of histamine in the first examination was considered to be significant. To our knowledge, central nervous system (CNS) dysfunction is quite rare in systemic mastocytosis and there has only been one autopsied case of cerebellar hemorrhagedue to mast cell infiltration (8) . Wesuspected that the multiple intracranial lesions showing T2-weighted high signal intensity with Tlweighted Gd-DTPAenhancement implied a regionally active inflammatory process. In these lesions, the blood-brain barrier must be destroyed. 
